Prosecution Insights
Last updated: August 18, 2026

Examiner: PARK, HAEJIN S

Tech Center 1600 • Art Units: 1611 1614 1615 1628

This examiner grants 55% of resolved cases

Performance Statistics

55.1%
Allow Rate
-4.9% vs TC avg
780
Total Applications
+38.5%
Interview Lift
1123
Avg Prosecution Days
Based on 729 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
13.1%
§102 Novelty
41.3%
§103 Obviousness
23.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18612755 MICROSPHERE-BASED DRUG DELIVERY PLATFORM FOR DELIVERY OF IMMUNOTHERAPEUTIC AGENTS Non-Final OA Boston Scientific Scimed, Inc.
18239036 PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT Final Rejection The University of North Carolina at Chapel Hill
19093009 PARTICLE-FORM HYBRID-SCALE FIBER MATRIX Non-Final OA Solventum Intellectual Properties Company
18695440 COMPOSITIONS FOR USE Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18713334 SOLID POWDER COSMETIC PRODUCT Non-Final OA SHISEIDO COMPANY, LTD.
18608586 ORALLY DISINTEGRATING NICOTINE TABLET FOR USE UNDER LIP Final Rejection Fertin Pharma A/S
18695554 SOLID COMPOSITION FOR DYEING KERATIN Non-Final OA KAO CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month